(2R,5S)-8-Hydroxy-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine 6,12-dioxide
| Product Name |
(2R,5S)-8-Hydroxy-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine 6,12-dioxide
|
| Product Code |
DA-B125-13
|
| Chemical name |
(2R,5S)-8-Hydroxy-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine 6,12-dioxide
|
| Synonyms |
2,3,4,5,7,9,13,13a-Octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine 6,12-dioxide, (2R,5S)-8-hydroxy-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-;
|
| Impurity |
NA
|
| CAS Number |
NA
|
| Alternate CAS # |
NA
|
| Molecular form |
C21H18F3N3O7
|
| Appearance |
NA
|
| Melting Point |
NA
|
| Mol. Weight |
481.38
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
pharmaceutical standards,impurities,intermediates,metabolites,fine chemicals
|
| Boiling Point |
NA
|
| Applications |
NA
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
